Current status and prospect of ZIF-based materials for breast cancer treatment

• Published in: Colloids and surfaces, B, Biointerfaces Vol. 232; p. 113612
• Main Authors: Zeng, Yana, Liao, Donghui, Kong, Xiangyang, Huang, Qianying, Zhong, Muyi, Liu, Jianqiang, Nezamzadeh-Ejhieh, Alireza, Pan, Ying, Song, Hailiang
• Format: Journal Article
• Language: English
• Published: 01-12-2023
• ISSN: 0927-7765; 1873-4367
• DOI: 10.1016/j.colsurfb.2023.113612

Breast cancer, one of the three most life-threatening cancers in modern times, must be explored for treatments with low side effects and practical efficacy. Metal organic framework materials (MOFs) is made by metal ions as the center for point and organic ligands as a bridge connecting a new type of porous nano-materials, among them, the zinc base zeolite imidazole skeleton material series (ZIFs) because of its excellent biocompatibility and pH slow controlled release ability, is widely used in the tumor microenvironment in basic research and achieved remarkable curative effect. Inspired by this, in this review, we focus on the recent research progress on the application of ZIFs in the treatment of breast cancer, mainly studying the structure of ZIFs such as ZIF-8, ZIF-90 and ZIF-67 and their application in novel therapies for breast cancer treatment, such as targeted drug delivery, photothermal therapy, immunotherapy and gene therapy.We will more fully demonstrate the potential of zif in breast cancer treatment, hoping to provide an avenue for exploring breast cancer treatment.